Skip to main content

Featured

Blast at Islamabad Mosque Leaves Dozens Dead

                    Blood stains at the site of a deadly explosion at a Shi'ite Muslim mosque in Islamabad, Pakistan A suicide bomber detonated explosives inside a crowded Shi’ite mosque in Islamabad, killing 31 people and injuring many others during Friday prayers. The attack struck the Tarlai neighborhood, where worshippers had gathered in large numbers, turning a moment of devotion into chaos and devastation. Witnesses described a powerful blast that shattered windows, collapsed parts of the structure, and left victims trapped beneath debris. Emergency teams and local residents worked together to rush the wounded to nearby hospitals, where several remain in critical condition. Authorities have heightened security across the capital as investigators work to determine how the attacker breached the area and whether others were involved. The bombing marks one of the deadliest assaults in the city in years and has intensified ...
Post a Comment
Read more

article

Labels

Pharmacare in Canada: A Dream or a Reality?

 


The fate of Canada's pharmacare plan is uncertain as the federal government faces challenges in implementing a universal drug coverage program, even if a bill to create one passes in Parliament. Bill C-213, the Canada Pharmacare Act, aims to establish a national framework for pharmacare that would ensure all Canadians have access to prescription drugs based on their medical needs, not their ability to pay. 

However, the bill does not specify how the program would be funded, administered or negotiated with the provinces and territories, leaving many questions unanswered about the feasibility and cost-effectiveness of pharmacare. Some experts and stakeholders have expressed doubts about whether Ottawa has the political will, the constitutional authority and the fiscal capacity to deliver on its promise of pharmacare, especially in the wake of the COVID-19 pandemic that has strained the health care system and the public purse.

Labels:

Comments

Post a Comment